Biovista Inc. and FDA to Collaborate on a Medication Safety Initiative

January 12, 2010Press Releases

CHARLOTTESVILLE, Virginia, January 12 /PRNewswire/ — Biovista Inc. today announced that the U.S. Food and Drug Administration (FDA) has licensed its technology platform to help analyze, identify, and better understand the way certain drugs can cause harmful side effects. The FDA’s Office of Clinical Pharmacology, within the Center for Drug Evaluation and Research (CDER), will … Read More